Advanced renal cell carcinoma: first results from the prospective research platform CARAT for patients with mRCC in Germany. Goebell PJ, Müller L, Grüllich C, Reichert D, Bögemann M, Dörfel S, von der Heyde E, Binninger A, Jänicke M, Marschner N, Staehler M, Grünwald V, 2019. Ann Oncol, Volume 30, v135 Similar effectiveness of R-CHOP-14 and -21 in diffuse large B-cell lymphoma – Data from the prospective German Tumour Registry Lymphatic Neoplasms. Knauf, W., Abenhardt, W., Mohm, J., Rauh, J., Harde, J., Kaiser-Osterhues, A., Jänicke, M., Marschner, N., TLN-Group; 2019. Eur J Haematol 00, 1–12. doi:10.1111/ejh.13295… Weiterlesen Palbociclib plus fulvestrant as second- or later-line therapy for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany: Interim results of the INGE-B phase 2 study. Lüftner D, Welslau M, Liersch R, Deryal M, Brucker C, Rauh J, Welt A, Zaiss M, Sahlmann J, Houet L, Vannier C, Potthoff K, Marschner… Weiterlesen